Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1990
05/31/1990WO1990005781A1 Neural cell transplantation
05/31/1990WO1990005780A1 Dopamine receptors and genes
05/31/1990WO1990005755A1 Collagen-polymer conjugates
05/31/1990WO1990005748A1 Scavenger receptor protein and antibody thereto
05/31/1990WO1990005747A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
05/31/1990WO1990005742A1 Fish crf
05/31/1990WO1990005741A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
05/31/1990WO1990005740A1 Improved extraction methods for preparing thromboplastin reagents
05/31/1990WO1990005737A1 Cloning and expression of a protein which modulates cellular response to type i interferon
05/31/1990WO1990005731A1 Cytotoxic macromolecules
05/31/1990WO1990005550A1 Organ transplant antiviral process
05/31/1990WO1990005548A1 Virus inactivated blood product and method
05/31/1990WO1990005547A1 Sperm antiviral process
05/31/1990WO1990005546A1 Improved antiviral blood sampling process and apparatus
05/31/1990WO1990005541A1 Immunotherapy involving cd28 stimulation
05/31/1990WO1990005540A1 Monoclonal antibodies specific for tumor antigens
05/31/1990WO1990005539A1 Antibodies specific for elam-1 and the use thereof
05/31/1990WO1990005537A1 Inhib, a factor which inhibits cytokine-activated leukocytes
05/31/1990WO1990005535A1 Interferon preparation for nasal administration
05/31/1990WO1990005534A1 Polypeptide derivatives
05/31/1990WO1990005533A1 Biologically competent, virus inactivated albumin
05/31/1990WO1990005532A1 Use of tnf in the treatment of skin diseases
05/31/1990WO1990005531A1 Method for treating vascular diseases
05/31/1990WO1990005530A1 Hybrid procoagulant proteins
05/31/1990WO1990005528A2 Anti-thrombotic steroids
05/31/1990WO1990005522A1 Pharmaceutical preparation
05/31/1990WO1990005520A2 Tissue culture antiviral processes and compositions
05/31/1990WO1990003435A3 Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure
05/31/1990WO1990002803A3 Viral vaccines
05/31/1990DE3938751A1 New oligopeptide with tetra:hydro:isoquinoline-carboxylic acid residue
05/31/1990DE3937539A1 Somatostatin and its analogues or derivs. - used for protection against lung damage, esp. respiratory distress syndrome or damage caused by oxygen therapy
05/31/1990DE3839639A1 Verwendung von tnf bei der behandlung von hautkrankheiten The use of TNF in the treatment of skin diseases
05/31/1990CA2004033A1 Fast buccal tablet
05/31/1990CA2004001A1 Amino acid derivatives
05/30/1990EP0371010A1 Absorbable calcitonin medicament
05/30/1990EP0370989A2 Human vascular permeability factor
05/30/1990EP0370711A1 Novel compounds
05/30/1990EP0370656A1 Treatment of myelosuppression associated with acquired immune deficiency
05/30/1990EP0370581A1 Anti-hCG antibodies
05/30/1990EP0370457A1 Lipid emulsion for treating aids
05/30/1990EP0370454A2 Renin-inhibiting amino diol derivatives
05/30/1990EP0370453A2 Peptides having a Brady kinine-inhibiting activity
05/30/1990EP0370383A2 Renin-inhibiting dipeptides, process to make them, compositions containing them and their use
05/30/1990EP0370382A2 Urea dipeptide derivatives with a renin-inhibiting activity, process to produce them, compositions containing them and their use
05/30/1990EP0370378A2 Pyrrolidine-2-carboxylic-acid derivatives with a psychotropic activity
05/30/1990EP0370283A2 Process for preparing 63-carboxyamides of teicoplanin antibiotics
05/30/1990EP0370171A2 Human nerve growth factor
05/30/1990EP0370165A2 Novel calcitonin derivative and salt thereof
05/30/1990EP0370052A1 Human granulocyte-macrophage colony stimulating factor and muteins thereof
05/30/1990EP0370049A1 Pellets with enzymatically controlled drug release
05/30/1990EP0370036A1 MODIFIED FACTOR VII/VIIa.
05/29/1990US4929700 Colony stimulating factor, genetic engineering
05/29/1990US4929604 Hydrolysis, purification
05/29/1990US4929602 Method of inhibiting platelet dependent arterial thrombosis
05/29/1990US4929601 Antitumor agents
05/29/1990US4929600 Endocrine manipulation to improve body composition of poultry
05/29/1990US4929554 Human immune interferon
05/29/1990US4929444 Low pH pharmaceutical formulation containing t-PA
05/29/1990US4929443 Method of treating interferon sensitive diseases, and a method and device for preparing γ-interferon containing preparation
05/29/1990US4929442 Compositions suitable for human topical application including a growth factor and/or related materials
05/29/1990CA1269800A1 4 h-3, 1-benzoxazin-4-ones and related compounds
05/29/1990CA1269799A1 Method for extracting protein with organic acid
05/29/1990CA1269617A1 Fibrinolysis-enhancing agents
05/25/1990CA2003773A1 Anti-hcg antibodies
05/23/1990EP0369943A1 Binding protein for insulin-like growth factors
05/23/1990EP0369877A1 Cloning and expression of a protein which modulates the cellular response to type I interferon
05/23/1990EP0369816A2 Monoclonal antibodies specific for human polymorphic epithelial mucin
05/23/1990EP0369664A2 Fish CRF
05/23/1990EP0369632A1 Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
05/23/1990EP0369516A2 Tailored beta-prime stable triglyceride hardstock
05/23/1990EP0369474A2 Pharmaceutical composition for the treatment of cerebral edema
05/23/1990EP0369437A2 Motilin preparation
05/23/1990EP0369425A1 Monoclonal antibody specifically recognizing N-glycolyl type GM2, hybridoma producing the antibody and method for preparing the hybridoma
05/23/1990EP0369413A2 Interferon-gamma binding proteins
05/23/1990EP0369391A2 N-substituted amides
05/23/1990EP0369316A2 Recombinant interleukin-2 hybrid proteins
05/23/1990EP0369141A1 Aspartic protease inhibitors for the treatment of diseases caused by retroviruses
05/23/1990EP0368920A1 Lectines fixing beta-d-galactoside.
05/23/1990EP0195084B1 Method of rectification of human leukocytic interferon
05/23/1990DE3838900A1 Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung Pyruvate kinase isoenzyme type m2 (m2 tumor-pk) specific antibodies / process for their production and their use
05/23/1990CN1042377A Process for preparing non-glycosylated recombining human il2 in reduced form
05/23/1990CN1042376A Nutritive liquid
05/23/1990CN1042364A Process for producing hemoglobin concentrate
05/23/1990CA2003743A1 Polypeptide derivatives
05/23/1990CA2003720A1 Lipid emulsion for treating aids
05/23/1990CA2003695A1 Position-specific insertion vectors and method of using same
05/22/1990US4927822 Hypotensive
05/22/1990US4927817 Preventive and therapeutic agent against liver disorder
05/22/1990US4927809 Anticoagulants
05/22/1990US4927807 Renin inhibiting amides
05/22/1990US4927806 Saturated salt/concentrated dextran formulation to treat hemorrhage
05/22/1990US4927630 Tissue plasminogen activator from normal human colon cells
05/22/1990US4927629 Phospholipase
05/22/1990US4927565 5-substituted amino-4-hydroxy-pentenoic acid derivatives and their use
05/22/1990CA2003325A1 Process for preparing 63 - carboxyamides of teicoplanin antibiotics
05/22/1990CA1269500A1 Muramyldipeptide active ester derivatives
05/22/1990CA1269499A1 Potent thymopentin analogs
05/22/1990CA1269498A1 Enzyme-resistant immunomodulatory peptides
05/22/1990CA1269497A1 Amino acid ester and amide renin inhibitors
05/22/1990CA1269496A1 Mercaptocycloalkylcarbonyl and mercaptoarylcarbonyl dipeptides
1 ... 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 ... 3163